Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PM2BP4
The NM_001077365.2(POMT1):āc.151A>Cā(p.Ile51Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,880 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
POMT1 (HGNC:9202): (protein O-mannosyltransferase 1) The protein encoded by this gene is an O-mannosyltransferase that requires interaction with the product of the POMT2 gene for enzymatic function. The encoded protein is found in the membrane of the endoplasmic reticulum. Defects in this gene are a cause of Walker-Warburg syndrome (WWS) and limb-girdle muscular dystrophy type 2K (LGMD2K). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Oct 2008]
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM1
In a transmembrane_region Helical (size 20) in uniprot entity POMT1_HUMAN there are 7 pathogenic changes around while only 1 benign (88%) in NM_001077365.2
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3275742).
Loss of catalytic residue at I51 (P = 0.0769);Loss of catalytic residue at I51 (P = 0.0769);Loss of catalytic residue at I51 (P = 0.0769);Loss of catalytic residue at I51 (P = 0.0769);